Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616984001> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2616984001 abstract "Background Some patients infected with multiresistant HIV receive lifelong antiretroviral (ARV) treatments. Long term drug effects on the patient and economic burden for society have to be weighed. These patients have a long virological history and a treatment optimisation strategy requires a multiparametric and individualised evaluation. Purpose Evaluating the clinical and economic impact of a therapeutic optimisation strategy for patients receiving multitherapy. Material and methods Eligible patients were receiving 4 ARV and had a viral load(VL) of 12 months. A multidisciplinary expert team suggested a new optimised treatment with Results Of the 4277 patients receiving HIV treatment, 146 were on >4 ARV drugs. 89 patient files were discussed with HIV experts, 82% treated with 4 ARV, 17% with 5 ARV and 1% with 6 ARV. Median age (min–max) was 58 years (33–85), HIV diagnostic period was 27 years (2–33), ARV treatment period was 22 (2–30) and number of treatment lines was 14 (2–32). To date, 71 (79.8%) patients have switched to tri- or bi-therapy (77.5% and 22.5%) and 56 (78.9%) have reached the first endpoint. Therapeutic optimisation leads to significant diminution of prescriptions for (non-)nucleoside reverse transcriptase inhibitors (−74%), protease inhibitors (−37%) and maraviroc (−48%). Only integrase inhibitors were prescribed more often after therapeutic optimisation (+6%, 77.5% of bi-therapies). The median monthly drug cost significantly decreased from €1746 to €1112 (−36%, Wilcoxon test) with annual savings of about €0.5M for this cohort. Cost savings remained significant even with the integration of laboratory costs (−26%). To date, virological suppression has been maintained in 93.0% of patients. Quality of life criteria will be analysed at the end of this ongoing study. Conclusion Multi-therapies represent a minor part of the current strategies. Therapeutic individualised optimisation reduces the daily number of ARV and has a significant economic impact, despite additional costs due to the resulting follow-up of a treatment switch, to ensure virological success and tolerance of the new treatment. No conflict of interest" @default.
- W2616984001 created "2017-06-05" @default.
- W2616984001 creator A5017386021 @default.
- W2616984001 creator A5019135867 @default.
- W2616984001 creator A5029704368 @default.
- W2616984001 creator A5035019350 @default.
- W2616984001 creator A5039272561 @default.
- W2616984001 creator A5048304227 @default.
- W2616984001 creator A5061527531 @default.
- W2616984001 creator A5076939929 @default.
- W2616984001 creator A5091495073 @default.
- W2616984001 creator A5057723212 @default.
- W2616984001 date "2017-02-25" @default.
- W2616984001 modified "2023-10-01" @default.
- W2616984001 title "CP-142 Antiretroviral therapy optimisation in multitreated hiv patients: clinical and pharmacoeconomic approach in the ecovir study" @default.
- W2616984001 doi "https://doi.org/10.1136/ejhpharm-2017-000640.141" @default.
- W2616984001 hasPublicationYear "2017" @default.
- W2616984001 type Work @default.
- W2616984001 sameAs 2616984001 @default.
- W2616984001 citedByCount "0" @default.
- W2616984001 crossrefType "proceedings-article" @default.
- W2616984001 hasAuthorship W2616984001A5017386021 @default.
- W2616984001 hasAuthorship W2616984001A5019135867 @default.
- W2616984001 hasAuthorship W2616984001A5029704368 @default.
- W2616984001 hasAuthorship W2616984001A5035019350 @default.
- W2616984001 hasAuthorship W2616984001A5039272561 @default.
- W2616984001 hasAuthorship W2616984001A5048304227 @default.
- W2616984001 hasAuthorship W2616984001A5057723212 @default.
- W2616984001 hasAuthorship W2616984001A5061527531 @default.
- W2616984001 hasAuthorship W2616984001A5076939929 @default.
- W2616984001 hasAuthorship W2616984001A5091495073 @default.
- W2616984001 hasConcept C126322002 @default.
- W2616984001 hasConcept C142462285 @default.
- W2616984001 hasConcept C159047783 @default.
- W2616984001 hasConcept C187212893 @default.
- W2616984001 hasConcept C203092338 @default.
- W2616984001 hasConcept C2426938 @default.
- W2616984001 hasConcept C2777302000 @default.
- W2616984001 hasConcept C2778899366 @default.
- W2616984001 hasConcept C2779182219 @default.
- W2616984001 hasConcept C2779502633 @default.
- W2616984001 hasConcept C2993143319 @default.
- W2616984001 hasConcept C3013748606 @default.
- W2616984001 hasConcept C3019165603 @default.
- W2616984001 hasConcept C535046627 @default.
- W2616984001 hasConcept C71924100 @default.
- W2616984001 hasConcept C98274493 @default.
- W2616984001 hasConceptScore W2616984001C126322002 @default.
- W2616984001 hasConceptScore W2616984001C142462285 @default.
- W2616984001 hasConceptScore W2616984001C159047783 @default.
- W2616984001 hasConceptScore W2616984001C187212893 @default.
- W2616984001 hasConceptScore W2616984001C203092338 @default.
- W2616984001 hasConceptScore W2616984001C2426938 @default.
- W2616984001 hasConceptScore W2616984001C2777302000 @default.
- W2616984001 hasConceptScore W2616984001C2778899366 @default.
- W2616984001 hasConceptScore W2616984001C2779182219 @default.
- W2616984001 hasConceptScore W2616984001C2779502633 @default.
- W2616984001 hasConceptScore W2616984001C2993143319 @default.
- W2616984001 hasConceptScore W2616984001C3013748606 @default.
- W2616984001 hasConceptScore W2616984001C3019165603 @default.
- W2616984001 hasConceptScore W2616984001C535046627 @default.
- W2616984001 hasConceptScore W2616984001C71924100 @default.
- W2616984001 hasConceptScore W2616984001C98274493 @default.
- W2616984001 hasLocation W26169840011 @default.
- W2616984001 hasOpenAccess W2616984001 @default.
- W2616984001 hasPrimaryLocation W26169840011 @default.
- W2616984001 hasRelatedWork W1724852996 @default.
- W2616984001 hasRelatedWork W187120464 @default.
- W2616984001 hasRelatedWork W1896705761 @default.
- W2616984001 hasRelatedWork W2024782797 @default.
- W2616984001 hasRelatedWork W2039893646 @default.
- W2616984001 hasRelatedWork W2125131699 @default.
- W2616984001 hasRelatedWork W2142232262 @default.
- W2616984001 hasRelatedWork W2152130601 @default.
- W2616984001 hasRelatedWork W2157497799 @default.
- W2616984001 hasRelatedWork W2405819844 @default.
- W2616984001 hasRelatedWork W2410067366 @default.
- W2616984001 hasRelatedWork W2503580454 @default.
- W2616984001 hasRelatedWork W2613569423 @default.
- W2616984001 hasRelatedWork W2625722257 @default.
- W2616984001 hasRelatedWork W2800221820 @default.
- W2616984001 hasRelatedWork W2906998293 @default.
- W2616984001 hasRelatedWork W2982270052 @default.
- W2616984001 hasRelatedWork W3137634162 @default.
- W2616984001 hasRelatedWork W2148095184 @default.
- W2616984001 hasRelatedWork W2738543552 @default.
- W2616984001 isParatext "false" @default.
- W2616984001 isRetracted "false" @default.
- W2616984001 magId "2616984001" @default.
- W2616984001 workType "article" @default.